Rain Enhancement Technologies Holdco, Inc. rose 58.3% on Friday, November 13, 2026, on 118,641,219 shares, 88 times its average daily volume. Headlines around the move:
Rain Enhancement Technologies Holdco, Inc. (RAIN:NASDAQ) closed at $0.750 on November 13, 2026, up 58.31% on the day. The stock trades 91.2% below its 52-week high of $8.52 and 63.0% above its 52-week low of $0.460. Over the past year, it lost 87.9%. Rain Enhancement Technologies Holdco, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, RAIN closed higher on 97 days (38%). Its best day was November 13, 2026 (+58.23%) and its worst was December 31, 2025 (-28.17%). The stock moved 10% or more in a single session 46 times. It opened at least 5% above the previous day's high 3 times.
Rain Therapeutics Inc is a clinical-stage precision oncology company developing therapies that target oncogenic drivers for which they are able to genetically select patients they believe will most likely benefit. Its lead product candidate, RAIN-32 is a small molecule, oral inhibitor of mouse double minute 2, which is oncogenic in numerous cancers.
Find more stocks like RAIN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.